HEADER HYDOLASE INHIBITOR 17-APR-12 4AQH TITLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR TITLE 2 AZ3976 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR INHIBITOR 1; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: PAI, PAI-1, ENDOTHELIAL PLASMINOGEN ACTIVATOR INHIBITOR, COMPND 5 SERPIN E1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS HYDOLASE INHIBITOR, LATENT FORM EXPDTA X-RAY DIFFRACTION AUTHOR O.FJELLSTROM,J.DEINUM,T.SJOGREN,C.JOHANSSON,S.GESCHWINDNER,V.NERME, AUTHOR 2 A.LEGNEHED,J.MCPHEAT,K.OLSSON,C.BODIN,D.GUSTAFSSON REVDAT 5 20-DEC-23 4AQH 1 REMARK REVDAT 4 08-MAY-19 4AQH 1 REMARK REVDAT 3 30-JAN-13 4AQH 1 JRNL REVDAT 2 16-JAN-13 4AQH 1 JRNL REVDAT 1 28-NOV-12 4AQH 0 JRNL AUTH O.FJELLSTROM,J.DEINUM,T.SJOGREN,C.JOHANSSON,S.GESCHWINDNER, JRNL AUTH 2 V.NERME,A.LEGNEHED,J.MCPHEAT,K.OLSSON,C.BODIN,A.PANUOVIC, JRNL AUTH 3 D.GUSTAFSSON JRNL TITL CHARACTERIZATION OF A SMALL MOLECULE INHIBITOR OF JRNL TITL 2 PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 THAT ACCELERATES THE JRNL TITL 3 TRANSITION INTO THE LATENT CONFORMATION JRNL REF J.BIOL.CHEM. V. 288 873 2013 JRNL REFN ISSN 0021-9258 JRNL PMID 23155046 JRNL DOI 10.1074/JBC.M112.371732 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0066 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 58169 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.159 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 3163 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4052 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.50 REMARK 3 BIN R VALUE (WORKING SET) : 0.2100 REMARK 3 BIN FREE R VALUE SET COUNT : 236 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9115 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 69 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.45000 REMARK 3 B22 (A**2) : 4.45000 REMARK 3 B33 (A**2) : -8.91000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.056 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.038 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.165 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.809 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9415 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12779 ; 1.485 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1144 ; 5.464 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 423 ;39.198 ;23.830 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1599 ;17.641 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 54 ;19.410 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1419 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7183 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5737 ; 0.826 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9323 ; 1.564 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3678 ; 2.358 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3450 ; 3.793 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.655 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : K, H, -L REMARK 3 TWIN FRACTION : 0.345 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4AQH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-APR-12. REMARK 100 THE DEPOSITION ID IS D_1290052065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62179 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 49.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1DVN REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PAI-1 WAS CONCENTRATED TO ABOUT 4 G/L REMARK 280 IN A BUFFER CONTAINING 10 MM SODIUM ACETATE PH 5.6, 150 MM REMARK 280 SODIUM CHLORIDE AND 1 MM EDTA. AZ3976 WAS DISSOLVED IN REMARK 280 DEUTERATED DMSO AND ADDED TO THE PROTEIN SAMPLE TO A FINAL REMARK 280 CONCENTRATION OF 0.3 MM. CRYSTALS WERE OBTAINED BY THE HANGING REMARK 280 DROP VAPOR DIFFUSION TECHNIQUE: 2.5 UL PROTEIN SAMPLE WAS MIXED REMARK 280 WITH 1 UL OF A WELL SOLUTION CONTAINING 2.0 M SODIUM CHLORIDE, REMARK 280 100 MM BIS-TRIS PH 6.8, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.23033 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 66.46067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 GLY C -3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 88 -55.88 67.92 REMARK 500 ASN A 329 -158.29 -131.42 REMARK 500 SER A 344 -176.27 75.42 REMARK 500 ALA A 345 -162.60 54.49 REMARK 500 ASP A 355 127.77 -175.16 REMARK 500 ARG A 356 115.78 -32.41 REMARK 500 SER B -2 107.34 113.97 REMARK 500 LYS B 88 -56.17 62.37 REMARK 500 SER B 344 168.75 75.84 REMARK 500 ALA B 345 -177.92 77.68 REMARK 500 ASP B 355 143.16 -175.79 REMARK 500 MET B 377 116.91 -37.67 REMARK 500 LYS C 88 -54.41 70.24 REMARK 500 ARG C 118 4.74 45.86 REMARK 500 ASP C 158 -134.31 -122.35 REMARK 500 SER C 182 -4.07 -55.67 REMARK 500 LEU C 309 -62.12 -101.76 REMARK 500 GLN C 312 -88.66 -65.48 REMARK 500 SER C 344 166.07 78.69 REMARK 500 ALA C 345 168.67 65.43 REMARK 500 ARG C 356 118.58 -36.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2066 DISTANCE = 7.93 ANGSTROMS REMARK 525 HOH C2067 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH C2068 DISTANCE = 7.21 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TB7 A 1380 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TB7 B 1380 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TB7 C 1380 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7C RELATED DB: PDB REMARK 900 HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A REMARK 900 PENTAPEPTIDE REMARK 900 RELATED ID: 1B3K RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 900 RELATED ID: 1C5G RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 900 RELATED ID: 1DB2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 1 REMARK 900 RELATED ID: 1DVM RELATED DB: PDB REMARK 900 ACTIVE FORM OF HUMAN PAI-1 REMARK 900 RELATED ID: 1DVN RELATED DB: PDB REMARK 900 LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) REMARK 900 RELATED ID: 1LJ5 RELATED DB: PDB REMARK 900 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATORINHIBITOR- REMARK 900 1(PAI-1) REMARK 900 RELATED ID: 1OC0 RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN REMARK 900 OF VITRONECTIN REMARK 900 RELATED ID: 9PAI RELATED DB: PDB REMARK 900 CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST FOUR RESIDUES ARE DERIVED FROM THE EXPRESSION REMARK 999 VECTOR. DBREF 4AQH A 1 379 UNP P05121 PAI1_HUMAN 24 402 DBREF 4AQH B 1 379 UNP P05121 PAI1_HUMAN 24 402 DBREF 4AQH C 1 379 UNP P05121 PAI1_HUMAN 24 402 SEQADV 4AQH GLY A -3 UNP P05121 EXPRESSION TAG SEQADV 4AQH SER A -2 UNP P05121 EXPRESSION TAG SEQADV 4AQH HIS A -1 UNP P05121 EXPRESSION TAG SEQADV 4AQH MET A 0 UNP P05121 EXPRESSION TAG SEQADV 4AQH GLY B -3 UNP P05121 EXPRESSION TAG SEQADV 4AQH SER B -2 UNP P05121 EXPRESSION TAG SEQADV 4AQH HIS B -1 UNP P05121 EXPRESSION TAG SEQADV 4AQH MET B 0 UNP P05121 EXPRESSION TAG SEQADV 4AQH GLY C -3 UNP P05121 EXPRESSION TAG SEQADV 4AQH SER C -2 UNP P05121 EXPRESSION TAG SEQADV 4AQH HIS C -1 UNP P05121 EXPRESSION TAG SEQADV 4AQH MET C 0 UNP P05121 EXPRESSION TAG SEQRES 1 A 383 GLY SER HIS MET VAL HIS HIS PRO PRO SER TYR VAL ALA SEQRES 2 A 383 HIS LEU ALA SER ASP PHE GLY VAL ARG VAL PHE GLN GLN SEQRES 3 A 383 VAL ALA GLN ALA SER LYS ASP ARG ASN VAL VAL PHE SER SEQRES 4 A 383 PRO TYR GLY VAL ALA SER VAL LEU ALA MET LEU GLN LEU SEQRES 5 A 383 THR THR GLY GLY GLU THR GLN GLN GLN ILE GLN ALA ALA SEQRES 6 A 383 MET GLY PHE LYS ILE ASP ASP LYS GLY MET ALA PRO ALA SEQRES 7 A 383 LEU ARG HIS LEU TYR LYS GLU LEU MET GLY PRO TRP ASN SEQRES 8 A 383 LYS ASP GLU ILE SER THR THR ASP ALA ILE PHE VAL GLN SEQRES 9 A 383 ARG ASP LEU LYS LEU VAL GLN GLY PHE MET PRO HIS PHE SEQRES 10 A 383 PHE ARG LEU PHE ARG SER THR VAL LYS GLN VAL ASP PHE SEQRES 11 A 383 SER GLU VAL GLU ARG ALA ARG PHE ILE ILE ASN ASP TRP SEQRES 12 A 383 VAL LYS THR HIS THR LYS GLY MET ILE SER ASN LEU LEU SEQRES 13 A 383 GLY LYS GLY ALA VAL ASP GLN LEU THR ARG LEU VAL LEU SEQRES 14 A 383 VAL ASN ALA LEU TYR PHE ASN GLY GLN TRP LYS THR PRO SEQRES 15 A 383 PHE PRO ASP SER SER THR HIS ARG ARG LEU PHE HIS LYS SEQRES 16 A 383 SER ASP GLY SER THR VAL SER VAL PRO MET MET ALA GLN SEQRES 17 A 383 THR ASN LYS PHE ASN TYR THR GLU PHE THR THR PRO ASP SEQRES 18 A 383 GLY HIS TYR TYR ASP ILE LEU GLU LEU PRO TYR HIS GLY SEQRES 19 A 383 ASP THR LEU SER MET PHE ILE ALA ALA PRO TYR GLU LYS SEQRES 20 A 383 GLU VAL PRO LEU SER ALA LEU THR ASN ILE LEU SER ALA SEQRES 21 A 383 GLN LEU ILE SER HIS TRP LYS GLY ASN MET THR ARG LEU SEQRES 22 A 383 PRO ARG LEU LEU VAL LEU PRO LYS PHE SER LEU GLU THR SEQRES 23 A 383 GLU VAL ASP LEU ARG LYS PRO LEU GLU ASN LEU GLY MET SEQRES 24 A 383 THR ASP MET PHE ARG GLN PHE GLN ALA ASP PHE THR SER SEQRES 25 A 383 LEU SER ASP GLN GLU PRO LEU HIS VAL ALA GLN ALA LEU SEQRES 26 A 383 GLN LYS VAL LYS ILE GLU VAL ASN GLU SER GLY THR VAL SEQRES 27 A 383 ALA SER SER SER THR ALA VAL ILE VAL SER ALA ARG MET SEQRES 28 A 383 ALA PRO GLU GLU ILE ILE MET ASP ARG PRO PHE LEU PHE SEQRES 29 A 383 VAL VAL ARG HIS ASN PRO THR GLY THR VAL LEU PHE MET SEQRES 30 A 383 GLY GLN VAL MET GLU PRO SEQRES 1 B 383 GLY SER HIS MET VAL HIS HIS PRO PRO SER TYR VAL ALA SEQRES 2 B 383 HIS LEU ALA SER ASP PHE GLY VAL ARG VAL PHE GLN GLN SEQRES 3 B 383 VAL ALA GLN ALA SER LYS ASP ARG ASN VAL VAL PHE SER SEQRES 4 B 383 PRO TYR GLY VAL ALA SER VAL LEU ALA MET LEU GLN LEU SEQRES 5 B 383 THR THR GLY GLY GLU THR GLN GLN GLN ILE GLN ALA ALA SEQRES 6 B 383 MET GLY PHE LYS ILE ASP ASP LYS GLY MET ALA PRO ALA SEQRES 7 B 383 LEU ARG HIS LEU TYR LYS GLU LEU MET GLY PRO TRP ASN SEQRES 8 B 383 LYS ASP GLU ILE SER THR THR ASP ALA ILE PHE VAL GLN SEQRES 9 B 383 ARG ASP LEU LYS LEU VAL GLN GLY PHE MET PRO HIS PHE SEQRES 10 B 383 PHE ARG LEU PHE ARG SER THR VAL LYS GLN VAL ASP PHE SEQRES 11 B 383 SER GLU VAL GLU ARG ALA ARG PHE ILE ILE ASN ASP TRP SEQRES 12 B 383 VAL LYS THR HIS THR LYS GLY MET ILE SER ASN LEU LEU SEQRES 13 B 383 GLY LYS GLY ALA VAL ASP GLN LEU THR ARG LEU VAL LEU SEQRES 14 B 383 VAL ASN ALA LEU TYR PHE ASN GLY GLN TRP LYS THR PRO SEQRES 15 B 383 PHE PRO ASP SER SER THR HIS ARG ARG LEU PHE HIS LYS SEQRES 16 B 383 SER ASP GLY SER THR VAL SER VAL PRO MET MET ALA GLN SEQRES 17 B 383 THR ASN LYS PHE ASN TYR THR GLU PHE THR THR PRO ASP SEQRES 18 B 383 GLY HIS TYR TYR ASP ILE LEU GLU LEU PRO TYR HIS GLY SEQRES 19 B 383 ASP THR LEU SER MET PHE ILE ALA ALA PRO TYR GLU LYS SEQRES 20 B 383 GLU VAL PRO LEU SER ALA LEU THR ASN ILE LEU SER ALA SEQRES 21 B 383 GLN LEU ILE SER HIS TRP LYS GLY ASN MET THR ARG LEU SEQRES 22 B 383 PRO ARG LEU LEU VAL LEU PRO LYS PHE SER LEU GLU THR SEQRES 23 B 383 GLU VAL ASP LEU ARG LYS PRO LEU GLU ASN LEU GLY MET SEQRES 24 B 383 THR ASP MET PHE ARG GLN PHE GLN ALA ASP PHE THR SER SEQRES 25 B 383 LEU SER ASP GLN GLU PRO LEU HIS VAL ALA GLN ALA LEU SEQRES 26 B 383 GLN LYS VAL LYS ILE GLU VAL ASN GLU SER GLY THR VAL SEQRES 27 B 383 ALA SER SER SER THR ALA VAL ILE VAL SER ALA ARG MET SEQRES 28 B 383 ALA PRO GLU GLU ILE ILE MET ASP ARG PRO PHE LEU PHE SEQRES 29 B 383 VAL VAL ARG HIS ASN PRO THR GLY THR VAL LEU PHE MET SEQRES 30 B 383 GLY GLN VAL MET GLU PRO SEQRES 1 C 383 GLY SER HIS MET VAL HIS HIS PRO PRO SER TYR VAL ALA SEQRES 2 C 383 HIS LEU ALA SER ASP PHE GLY VAL ARG VAL PHE GLN GLN SEQRES 3 C 383 VAL ALA GLN ALA SER LYS ASP ARG ASN VAL VAL PHE SER SEQRES 4 C 383 PRO TYR GLY VAL ALA SER VAL LEU ALA MET LEU GLN LEU SEQRES 5 C 383 THR THR GLY GLY GLU THR GLN GLN GLN ILE GLN ALA ALA SEQRES 6 C 383 MET GLY PHE LYS ILE ASP ASP LYS GLY MET ALA PRO ALA SEQRES 7 C 383 LEU ARG HIS LEU TYR LYS GLU LEU MET GLY PRO TRP ASN SEQRES 8 C 383 LYS ASP GLU ILE SER THR THR ASP ALA ILE PHE VAL GLN SEQRES 9 C 383 ARG ASP LEU LYS LEU VAL GLN GLY PHE MET PRO HIS PHE SEQRES 10 C 383 PHE ARG LEU PHE ARG SER THR VAL LYS GLN VAL ASP PHE SEQRES 11 C 383 SER GLU VAL GLU ARG ALA ARG PHE ILE ILE ASN ASP TRP SEQRES 12 C 383 VAL LYS THR HIS THR LYS GLY MET ILE SER ASN LEU LEU SEQRES 13 C 383 GLY LYS GLY ALA VAL ASP GLN LEU THR ARG LEU VAL LEU SEQRES 14 C 383 VAL ASN ALA LEU TYR PHE ASN GLY GLN TRP LYS THR PRO SEQRES 15 C 383 PHE PRO ASP SER SER THR HIS ARG ARG LEU PHE HIS LYS SEQRES 16 C 383 SER ASP GLY SER THR VAL SER VAL PRO MET MET ALA GLN SEQRES 17 C 383 THR ASN LYS PHE ASN TYR THR GLU PHE THR THR PRO ASP SEQRES 18 C 383 GLY HIS TYR TYR ASP ILE LEU GLU LEU PRO TYR HIS GLY SEQRES 19 C 383 ASP THR LEU SER MET PHE ILE ALA ALA PRO TYR GLU LYS SEQRES 20 C 383 GLU VAL PRO LEU SER ALA LEU THR ASN ILE LEU SER ALA SEQRES 21 C 383 GLN LEU ILE SER HIS TRP LYS GLY ASN MET THR ARG LEU SEQRES 22 C 383 PRO ARG LEU LEU VAL LEU PRO LYS PHE SER LEU GLU THR SEQRES 23 C 383 GLU VAL ASP LEU ARG LYS PRO LEU GLU ASN LEU GLY MET SEQRES 24 C 383 THR ASP MET PHE ARG GLN PHE GLN ALA ASP PHE THR SER SEQRES 25 C 383 LEU SER ASP GLN GLU PRO LEU HIS VAL ALA GLN ALA LEU SEQRES 26 C 383 GLN LYS VAL LYS ILE GLU VAL ASN GLU SER GLY THR VAL SEQRES 27 C 383 ALA SER SER SER THR ALA VAL ILE VAL SER ALA ARG MET SEQRES 28 C 383 ALA PRO GLU GLU ILE ILE MET ASP ARG PRO PHE LEU PHE SEQRES 29 C 383 VAL VAL ARG HIS ASN PRO THR GLY THR VAL LEU PHE MET SEQRES 30 C 383 GLY GLN VAL MET GLU PRO HET TB7 A1380 23 HET TB7 B1380 23 HET TB7 C1380 23 HETNAM TB7 TERT-BUTYL 3-[(4-OXO-3H-PYRIDO[2,3-D]PYRIMIDIN-2-YL) HETNAM 2 TB7 AMINO]AZETIDINE-1-CARBOXYLATE FORMUL 4 TB7 3(C15 H19 N5 O3) FORMUL 7 HOH *244(H2 O) HELIX 1 1 HIS A 3 SER A 6 5 4 HELIX 2 2 TYR A 7 GLN A 25 1 19 HELIX 3 3 SER A 35 THR A 50 1 16 HELIX 4 4 GLY A 51 GLY A 63 1 13 HELIX 5 5 GLY A 70 GLY A 84 1 15 HELIX 6 6 PRO A 85 LYS A 88 5 4 HELIX 7 7 GLY A 108 ARG A 118 1 11 HELIX 8 8 GLU A 128 THR A 144 1 17 HELIX 9 9 PRO A 180 THR A 184 5 5 HELIX 10 10 LEU A 247 ASN A 252 1 6 HELIX 11 11 SER A 255 ASN A 265 1 11 HELIX 12 12 LEU A 286 LEU A 293 1 8 HELIX 13 13 THR A 296 ARG A 300 5 5 HELIX 14 14 PRO B 4 SER B 6 5 3 HELIX 15 15 TYR B 7 SER B 27 1 21 HELIX 16 16 SER B 35 THR B 50 1 16 HELIX 17 17 GLY B 51 GLY B 63 1 13 HELIX 18 18 GLY B 70 GLY B 84 1 15 HELIX 19 19 PRO B 85 LYS B 88 5 4 HELIX 20 20 GLY B 108 ARG B 118 1 11 HELIX 21 21 GLU B 128 THR B 144 1 17 HELIX 22 22 PRO B 180 THR B 184 5 5 HELIX 23 23 LEU B 247 ASN B 252 1 6 HELIX 24 24 SER B 255 ASN B 265 1 11 HELIX 25 25 LEU B 286 LEU B 293 1 8 HELIX 26 26 THR B 296 ARG B 300 5 5 HELIX 27 27 HIS C 3 SER C 6 5 4 HELIX 28 28 TYR C 7 ALA C 26 1 20 HELIX 29 29 SER C 35 THR C 50 1 16 HELIX 30 30 GLY C 51 GLY C 63 1 13 HELIX 31 31 GLY C 70 GLY C 84 1 15 HELIX 32 32 PRO C 85 LYS C 88 5 4 HELIX 33 33 VAL C 106 GLY C 108 5 3 HELIX 34 34 PHE C 109 ARG C 118 1 10 HELIX 35 35 GLU C 128 THR C 144 1 17 HELIX 36 36 PRO C 180 THR C 184 5 5 HELIX 37 37 LEU C 247 ASN C 252 1 6 HELIX 38 38 SER C 255 ASN C 265 1 11 HELIX 39 39 LEU C 286 LEU C 293 1 8 HELIX 40 40 THR C 296 ARG C 300 5 5 SHEET 1 AA 7 VAL A 32 PHE A 34 0 SHEET 2 AA 7 THR A 369 MET A 377 -1 O MET A 373 N PHE A 34 SHEET 3 AA 7 PRO A 357 HIS A 364 -1 O PHE A 358 N VAL A 376 SHEET 4 AA 7 LEU A 233 PRO A 240 -1 O SER A 234 N ARG A 363 SHEET 5 AA 7 TYR A 220 PRO A 227 -1 O ASP A 222 N ALA A 239 SHEET 6 AA 7 THR A 196 THR A 214 -1 O ASN A 209 N GLU A 225 SHEET 7 AA 7 THR A 267 PRO A 276 -1 O THR A 267 N TYR A 210 SHEET 1 AB 7 VAL A 32 PHE A 34 0 SHEET 2 AB 7 THR A 369 MET A 377 -1 O MET A 373 N PHE A 34 SHEET 3 AB 7 PRO A 357 HIS A 364 -1 O PHE A 358 N VAL A 376 SHEET 4 AB 7 LEU A 233 PRO A 240 -1 O SER A 234 N ARG A 363 SHEET 5 AB 7 TYR A 220 PRO A 227 -1 O ASP A 222 N ALA A 239 SHEET 6 AB 7 THR A 196 THR A 214 -1 O ASN A 209 N GLU A 225 SHEET 7 AB 7 HIS A 185 HIS A 190 -1 O HIS A 185 N MET A 201 SHEET 1 AC 2 THR A 267 PRO A 276 0 SHEET 2 AC 2 THR A 196 THR A 214 -1 O MET A 202 N LEU A 275 SHEET 1 AD 6 LYS A 122 VAL A 124 0 SHEET 2 AD 6 GLU A 90 GLN A 100 1 O ILE A 97 N LYS A 122 SHEET 3 AD 6 LEU A 163 GLN A 174 -1 O VAL A 164 N PHE A 98 SHEET 4 AD 6 GLY A 332 ILE A 342 -1 O THR A 333 N GLY A 173 SHEET 5 AD 6 GLN A 319 VAL A 328 -1 O GLN A 319 N ILE A 342 SHEET 6 AD 6 SER A 279 ASP A 285 -1 O LEU A 280 N ILE A 326 SHEET 1 BA 7 VAL B 32 PHE B 34 0 SHEET 2 BA 7 THR B 369 MET B 377 -1 O MET B 373 N PHE B 34 SHEET 3 BA 7 PRO B 357 HIS B 364 -1 O PHE B 358 N VAL B 376 SHEET 4 BA 7 LEU B 233 PRO B 240 -1 O SER B 234 N ARG B 363 SHEET 5 BA 7 TYR B 220 PRO B 227 -1 O ASP B 222 N ALA B 239 SHEET 6 BA 7 THR B 196 THR B 214 -1 O ASN B 209 N GLU B 225 SHEET 7 BA 7 THR B 267 PRO B 276 -1 O THR B 267 N TYR B 210 SHEET 1 BB 7 VAL B 32 PHE B 34 0 SHEET 2 BB 7 THR B 369 MET B 377 -1 O MET B 373 N PHE B 34 SHEET 3 BB 7 PRO B 357 HIS B 364 -1 O PHE B 358 N VAL B 376 SHEET 4 BB 7 LEU B 233 PRO B 240 -1 O SER B 234 N ARG B 363 SHEET 5 BB 7 TYR B 220 PRO B 227 -1 O ASP B 222 N ALA B 239 SHEET 6 BB 7 THR B 196 THR B 214 -1 O ASN B 209 N GLU B 225 SHEET 7 BB 7 HIS B 185 HIS B 190 -1 O HIS B 185 N MET B 201 SHEET 1 BC 2 THR B 267 PRO B 276 0 SHEET 2 BC 2 THR B 196 THR B 214 -1 O MET B 202 N LEU B 275 SHEET 1 BD 6 LYS B 122 VAL B 124 0 SHEET 2 BD 6 GLU B 90 GLN B 100 1 O ILE B 97 N LYS B 122 SHEET 3 BD 6 LEU B 163 GLN B 174 -1 O VAL B 164 N PHE B 98 SHEET 4 BD 6 GLY B 332 VAL B 343 -1 O THR B 333 N GLY B 173 SHEET 5 BD 6 VAL B 317 VAL B 328 -1 N ALA B 318 O ILE B 342 SHEET 6 BD 6 PHE B 278 ASP B 285 -1 O PHE B 278 N VAL B 328 SHEET 1 CA 7 VAL C 32 PHE C 34 0 SHEET 2 CA 7 THR C 369 MET C 377 -1 O MET C 373 N PHE C 34 SHEET 3 CA 7 PRO C 357 HIS C 364 -1 O PHE C 358 N VAL C 376 SHEET 4 CA 7 LEU C 233 PRO C 240 -1 O SER C 234 N ARG C 363 SHEET 5 CA 7 TYR C 220 PRO C 227 -1 O ASP C 222 N ALA C 239 SHEET 6 CA 7 THR C 196 THR C 214 -1 O ASN C 209 N GLU C 225 SHEET 7 CA 7 THR C 267 PRO C 276 -1 O THR C 267 N TYR C 210 SHEET 1 CB 7 VAL C 32 PHE C 34 0 SHEET 2 CB 7 THR C 369 MET C 377 -1 O MET C 373 N PHE C 34 SHEET 3 CB 7 PRO C 357 HIS C 364 -1 O PHE C 358 N VAL C 376 SHEET 4 CB 7 LEU C 233 PRO C 240 -1 O SER C 234 N ARG C 363 SHEET 5 CB 7 TYR C 220 PRO C 227 -1 O ASP C 222 N ALA C 239 SHEET 6 CB 7 THR C 196 THR C 214 -1 O ASN C 209 N GLU C 225 SHEET 7 CB 7 HIS C 185 HIS C 190 -1 O HIS C 185 N MET C 201 SHEET 1 CC 2 THR C 267 PRO C 276 0 SHEET 2 CC 2 THR C 196 THR C 214 -1 O MET C 202 N LEU C 275 SHEET 1 CD 6 LYS C 122 VAL C 124 0 SHEET 2 CD 6 GLU C 90 GLN C 100 1 O ILE C 97 N LYS C 122 SHEET 3 CD 6 LEU C 163 GLN C 174 -1 O VAL C 164 N PHE C 98 SHEET 4 CD 6 GLY C 332 ILE C 342 -1 O THR C 333 N GLY C 173 SHEET 5 CD 6 GLN C 319 VAL C 328 -1 O GLN C 319 N ILE C 342 SHEET 6 CD 6 SER C 279 ASP C 285 -1 O LEU C 280 N ILE C 326 SITE 1 AC1 11 TYR A 37 SER A 41 ALA A 44 LEU A 75 SITE 2 AC1 11 ARG A 76 LEU A 78 TYR A 79 THR A 94 SITE 3 AC1 11 ASP A 95 PHE A 117 ARG A 118 SITE 1 AC2 10 TYR B 37 SER B 41 ALA B 44 ARG B 76 SITE 2 AC2 10 LEU B 78 TYR B 79 THR B 94 ASP B 95 SITE 3 AC2 10 PHE B 117 ARG B 118 SITE 1 AC3 11 TYR C 37 SER C 41 ALA C 44 ARG C 76 SITE 2 AC3 11 LEU C 78 TYR C 79 THR C 94 ASP C 95 SITE 3 AC3 11 LEU C 116 PHE C 117 ARG C 118 CRYST1 119.399 119.399 99.691 90.00 90.00 120.00 P 31 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008375 0.004835 0.000000 0.00000 SCALE2 0.000000 0.009671 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010031 0.00000